Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
•
Immunosuppression
How do you approach use of immunosuppressants in patients with rheumatologic disease and active intravenous drug use?
Related Questions
Do you routinely obtain urine pregnancy tests in patients on immunosuppression who use only a single method of contraception?
How do you approach endocarditis prophylaxis for patients with rheumatic diseases undergoing invasive dental surgery and no history of joint replacement?
What is your approach to a patient on immunosuppressants with an outpatient cutaneous MRSA infection or to a MRSA carrier?
What is your approach to tapering chronic steroids in patients who are at high risk of HPA suppression?
What is your approach to RSV vaccination in immunocompromised patients?
Do you consider IgM or IgA levels in addition to IgG levels when planning further doses of rituximab?
What is your approach to working up diarrhea in an immunocompromised patient?
Would you consider a biologic or JAK inhibitor to manage active PsA in a patient on chronic antibiotic therapy if they had previously failed all conventional DMARDs (including apremilast)?
How do you manage a patient with severe RA or SLE that worsens after stopping immunosuppressants due to having chronic foot ulceration?
What is your approach to continuing or altering therapy when inheriting a patient with combined biologic immunosuppression that is in excess of guidelines?
